TriClip Delivery System
ABBOTT MEDICAL · Decision date Aug 18, 2025
What did the FDA decide?
FDA records P230007/S016 as a supplement to PMA P230007, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 18, 2025.
FDA approval order statement
to change the incoming inspection sampling plan for components of the TriClip and MitraClip Delivery Systems from an Attribute Acceptable Quality Limit (AQL) to a variable-based plan with custom sampling plan requirements
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 18, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P230007/S016
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- NPS
- Decision code
- OK30
- Decision date
- Aug 18, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tricuspid valve repair device, percutaneously delivered.
- Applicant
- Abbott Medical
- Product code
- NPS
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P230007/S016 received
Application receipt date recorded by FDA.
P230007/S016 · FDA decision
30-Day Notice
P230007/S015 · Related supplement
TriClip G5 Delivery System
P230007/S017 · Related supplement
TriClip G4 Delivery System; TriClip G5 Delivery System
P230007/S018 · Related supplement
TriClip G4 System
P230007/S019 · Related supplement
TriClip G5 Delivery System (TCDS0801-NT, TCDS0801-NTW, TCDS0801-XT, TCDS0801-XTW)
P230007/S020 · Related supplement
TriClip G4 System
P230007/S021 · Related supplement
TriClip Systems
P230007/S022 · Related supplement
TriClip Delivery System
P230007/S023 · Related supplement
TriClip Systems
Timeline entries are records held by MedtechLedger for P230007. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230007
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TriClip G5 Delivery SystemP230007/S015 | ABBOTT MEDICAL | PMA supplement | Aug 20, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2025 | FDA | |
TriClip G4 SystemP230007/S018 | ABBOTT MEDICAL | PMA supplement | Oct 17, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 25, 2026 | FDA | |
TriClip G4 SystemP230007/S020 | ABBOTT MEDICAL | PMA supplement | Mar 6, 2026 | FDA |
TriClip SystemsP230007/S021 | ABBOTT MEDICAL | PMA supplement | May 14, 2026 | FDA |
TriClip Delivery SystemP230007/S022 | ABBOTT MEDICAL | PMA supplement | May 28, 2026 | FDA |
TriClip SystemsP230007/S023 | ABBOTT MEDICAL | PMA supplement | Jun 25, 2026 | FDA |
Explore the linked device profile
Other records with product code NPS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 20, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 177 County Rd. B E., St. Paul, MN, 55117
Sources and methodology
- Original FDA record: P230007/S016
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




